NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Caplight Logo









OZ Biosciences

OZ Biosciences

Private
MarseilleHealthcare & Life Scienceshttps://ozbiosciences.com/

Last Round

Grant

Jan 1, 2020

Total Funding Raised

$16.79M

Momentum Score

25 /100

Company Overview

OZ Biosciences is a life sciences company that develops and produces molecular delivery systems designed for transfection and transduction.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

molecular deliverytransfection reagentsMagnetofectionlipid nanoparticlesLNPgene deliverytransduction toolsmagnetic nanoparticlesmRNA synthesisLNP formulationCRISPR deliveryprotein deliverydrug delivery systemsvaccine adjuvantsbiotech reagents3D transfection

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OZ Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OZ Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
GrantJan 1, 2020
GrantNov 1, 2016
GrantOct 1, 2013
GrantJan 1, 2010
GrantApr 1, 2006
Grant
Jan 1, 2006

OZ Biosciences Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 136% MoM, reaching 20.6K.

  • May 2, 2025

    Monthly visitors grew 49% MoM, reaching 11.3K.

OZ Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OZ Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OZ Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersMarseille
Employee Range21
Year Founded2003
Last FundingJan 1, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.